BIOMAT Database Logo BIOMAT Database Logo

Differential expression of beta-catenin in human glioblastoma multiforme and normal brain tissue. 2000

H Yano, and A Hara, and K Takenaka, and K Nakatani, and J Shinoda, and K Shimokawa, and N Yoshimi, and H Mori, and N Sakai
Department of Neurosurgery, Gifu University School of Medicine, Japan. hirohito@cc.gifu-u.ac.jp

Angiogenesis is considered to play an important role in the development of malignant brain tumors, especially glioblastoma multiforme (GBM). Abnormal vascular construction with a glomeruloid appearance is characteristic of GBM. beta-catenin is known as one of the adhesive molecules associated not only with cell adhesion and cell polarity, but also with carcinogenesis. We postulated the relevance of beta-catenin to vigorous endothelial proliferation in human GBM because the vascular cells (VCs) are apt to lose their cell polarity. The object of this study is to compare the immunohistochemical localization of beta-catenin in VCs between GBMs and normal brain tissues. Immunohistochemical analysis of beta-catenin for VCs in 32 GBMs and 10 normal brain tissues was performed. beta-catenin was found concentrated in the areas of vascular cell-cell junction and internal surface of the vascular lumen in all normal brains. In contrast, beta-catenin, in proliferating VCs in GBMs, was stained homogeneously and intensely in the cytoplasms of 26 cases (81.3%), in which nuclear staining of beta-catenin was also recognized in four cases (12.5%). In conclusion, the intracellular localization of beta-catenin in VCs of GBMs was found to be different from that of normal brain tissues. The changes of expression of beta-catenin may be associated with the angiogenesis or transformation of the VCs in human GBM.

UI MeSH Term Description Entries
D007365 Intercellular Junctions Direct contact of a cell with a neighboring cell. Most such junctions are too small to be resolved by light microscopy, but they can be visualized by conventional or freeze-fracture electron microscopy, both of which show that the interacting CELL MEMBRANE and often the underlying CYTOPLASM and the intervening EXTRACELLULAR SPACE are highly specialized in these regions. (From Alberts et al., Molecular Biology of the Cell, 2d ed, p792) Cell Junctions,Cell Junction,Intercellular Junction,Junction, Cell,Junction, Intercellular,Junctions, Cell,Junctions, Intercellular
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D003598 Cytoskeletal Proteins Major constituent of the cytoskeleton found in the cytoplasm of eukaryotic cells. They form a flexible framework for the cell, provide attachment points for organelles and formed bodies, and make communication between parts of the cell possible. Proteins, Cytoskeletal
D004730 Endothelium, Vascular Single pavement layer of cells which line the luminal surface of the entire vascular system and regulate the transport of macromolecules and blood components. Capillary Endothelium,Vascular Endothelium,Capillary Endotheliums,Endothelium, Capillary,Endotheliums, Capillary,Endotheliums, Vascular,Vascular Endotheliums
D005909 Glioblastoma A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures. Astrocytoma, Grade IV,Giant Cell Glioblastoma,Glioblastoma Multiforme,Astrocytomas, Grade IV,Giant Cell Glioblastomas,Glioblastoma, Giant Cell,Glioblastomas,Glioblastomas, Giant Cell,Grade IV Astrocytoma,Grade IV Astrocytomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015534 Trans-Activators Diffusible gene products that act on homologous or heterologous molecules of viral or cellular DNA to regulate the expression of proteins. Nuclear Trans-Acting Factor,Trans-Acting Factors,Trans-Acting Factor,Trans-Activator,Transactivator,Transactivators,Factor, Nuclear Trans-Acting,Factor, Trans-Acting,Factors, Trans-Acting,Nuclear Trans Acting Factor,Trans Acting Factor,Trans Acting Factors,Trans Activator,Trans Activators,Trans-Acting Factor, Nuclear
D051176 beta Catenin A multi-functional catenin that participates in CELL ADHESION and nuclear signaling. Beta catenin binds CADHERINS and helps link their cytoplasmic tails to the ACTIN in the CYTOSKELETON via ALPHA CATENIN. It also serves as a transcriptional co-activator and downstream component of WNT PROTEIN-mediated SIGNAL TRANSDUCTION PATHWAYS. beta-Catenin,Catenin, beta

Related Publications

H Yano, and A Hara, and K Takenaka, and K Nakatani, and J Shinoda, and K Shimokawa, and N Yoshimi, and H Mori, and N Sakai
Comparison of cell adhesion molecule expression between glioblastoma multiforme and autologous normal brain tissue.
March 1995, Journal of neuroimmunology,
H Yano, and A Hara, and K Takenaka, and K Nakatani, and J Shinoda, and K Shimokawa, and N Yoshimi, and H Mori, and N Sakai
Differential expression of Wnt genes, beta-catenin and E-cadherin in human brain tumors.
September 2002, Cancer letters,
H Yano, and A Hara, and K Takenaka, and K Nakatani, and J Shinoda, and K Shimokawa, and N Yoshimi, and H Mori, and N Sakai
Enzymatic deamination of 8-azaguanine in normal human brain and in glioblastoma multiforme.
February 1953, Cancer research,
H Yano, and A Hara, and K Takenaka, and K Nakatani, and J Shinoda, and K Shimokawa, and N Yoshimi, and H Mori, and N Sakai
Concentration of elements in human brain: glioblastoma multiforme.
November 1993, The Science of the total environment,
H Yano, and A Hara, and K Takenaka, and K Nakatani, and J Shinoda, and K Shimokawa, and N Yoshimi, and H Mori, and N Sakai
Differential expression of HIF-1 in glioblastoma multiforme and anaplastic astrocytoma.
October 2012, International journal of oncology,
H Yano, and A Hara, and K Takenaka, and K Nakatani, and J Shinoda, and K Shimokawa, and N Yoshimi, and H Mori, and N Sakai
Functional and phenotypic differences between glioblastoma multiforme-derived and normal human brain endothelial cells.
April 2005, Journal of neurosurgery,
H Yano, and A Hara, and K Takenaka, and K Nakatani, and J Shinoda, and K Shimokawa, and N Yoshimi, and H Mori, and N Sakai
Upregulation of beta-amyloid precursor protein expression in glioblastoma multiforme.
June 2008, Neuroreport,
H Yano, and A Hara, and K Takenaka, and K Nakatani, and J Shinoda, and K Shimokawa, and N Yoshimi, and H Mori, and N Sakai
Differential gene expression analysis in glioblastoma cells and normal human brain cells based on GEO database.
November 2017, Oncology letters,
H Yano, and A Hara, and K Takenaka, and K Nakatani, and J Shinoda, and K Shimokawa, and N Yoshimi, and H Mori, and N Sakai
E-cadherin and beta-catenin expression in normal, inflamed and cancerous gallbladder tissue.
January 2005, Anticancer research,
H Yano, and A Hara, and K Takenaka, and K Nakatani, and J Shinoda, and K Shimokawa, and N Yoshimi, and H Mori, and N Sakai
Analysis of beta-catenin mutations and alpha-, beta-, and gamma-catenin expression in normal and neoplastic human pituitary tissues.
January 2001, Endocrine pathology,
Copied contents to your clipboard!